Pharmaceuticals Portfolio Financial Statements From 2010 to 2026
| FPHAX Fund | USD 31.29 0.03 0.1% |
Check Pharmaceuticals Portfolio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pharmaceuticals Portfolio's main balance sheet or income statement drivers, such as , as well as many indicators such as . Pharmaceuticals financial statements analysis is a perfect complement when working with Pharmaceuticals Portfolio Valuation or Volatility modules.
Pharmaceuticals |
Pharmaceuticals Portfolio Pharmaceuticals Mutual Fund Price To Sales Analysis
Pharmaceuticals Portfolio's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Pharmaceuticals Portfolio Price To Sales | 3.00 X |
Most of Pharmaceuticals Portfolio's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pharmaceuticals Portfolio Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Pharmaceuticals Portfolio Pharmaceuticals has a Price To Sales of 3.0 times. This is 233.33% higher than that of the Fidelity Investments family and significantly higher than that of the Health category. The price to sales for all United States funds is notably lower than that of the firm.
Pharmaceuticals Portfolio Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Pharmaceuticals Portfolio's current stock value. Our valuation model uses many indicators to compare Pharmaceuticals Portfolio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pharmaceuticals Portfolio competition to find correlations between indicators driving Pharmaceuticals Portfolio's intrinsic value. More Info.Pharmaceuticals Portfolio Pharmaceuticals is one of the top funds in price to earning among similar funds. It also is one of the top funds in price to book among similar funds fabricating about 0.11 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Pharmaceuticals Portfolio Pharmaceuticals is roughly 9.10 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pharmaceuticals Portfolio's earnings, one of the primary drivers of an investment's value.About Pharmaceuticals Portfolio Financial Statements
Pharmaceuticals Portfolio investors use historical fundamental indicators, such as Pharmaceuticals Portfolio's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Pharmaceuticals Portfolio. Please read more on our technical analysis and fundamental analysis pages.
The fund normally invests at least 80 percent of assets in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types. Fidelity Select is traded on NASDAQ Exchange in the United States.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Pharmaceuticals Mutual Fund
Pharmaceuticals Portfolio financial ratios help investors to determine whether Pharmaceuticals Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmaceuticals with respect to the benefits of owning Pharmaceuticals Portfolio security.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |